The Effect of Selective Intestinal Decontamination on the Hyperdynamic Circulatory State in Cirrhosis: A Randomized Trial

Annals of Internal Medicine

Volumn 139, Issue 3, 2003, Pages

  Rasaratnam, Brindhesha ^a   Kaye, David ^a   Jennings, Garry ^a   Dudley, Francis ^a   Chin Dusting, Jaye P F ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; INSULIN; NITRIC OXIDE; NORFLOXACIN; PLACEBO; ANTIINFECTIVE AGENT;

ADULT; ALCOHOL LIVER CIRRHOSIS; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FOREARM BLOOD FLOW; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HEART OUTPUT; HEMODYNAMICS; HUMAN; INSULIN CLEARANCE; INTESTINAL DECONTAMINATION; LIMULUS LYSATE TEST; MALE; MEAN ARTERIAL PRESSURE; PATHOGENESIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY; VENOUS PRESSURE; BACTERIAL TRANSLOCATION; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; FOREARM; PATHOPHYSIOLOGY; VASCULARIZATION;

ANTI-INFECTIVE AGENTS; BACTERIAL TRANSLOCATION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENDOTOXINS; FOREARM; GLOMERULAR FILTRATION RATE; HEMODYNAMIC PROCESSES; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; NITRIC OXIDE; NORFLOXACIN;

EID: 1642535481     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-139-3-200308050-00008     Document Type: Article

References (21)

1. Llach J, Gines P, Arroyo V, Rimola A, Tito L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology. 1988;94:482-7. [PMID: 3335320]
2. Hori N, Okanoue T, Mori T, Kashima K, Nishimura M, Nanbu A, et al. Endogenous nitric oxide production is augmented as the severity advances in patients with liver cirrhosis. Clin Exp Pharmacol Physiol. 1996;23:30-5. [PMID: 8713493]
3. Maain PY, Xu DL, Niederberger M, Weigert A, Tsai P, St John J, et al. Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am J Physiol. 1996;270:F494-9. [PMID: 8780253]
4. Morales-Ruiz M, Jimenez W, Perez-Sala D, Ros J, Leivas A, Lamas S, et al. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology. 1996;24:1481-6. [PMID: 8938184]
5. Sanchez-Rodriguez A, Criado M, Rodriguez-Lopez AM, Esteller A, Martin de Arriba A, Lopex-Novoa JM. Increased nitric oxide synthesis and inducible nitric oxide synthase expression in patients with alcoholic and non-alcoholic liver cirrhosis. Clin Sci (Lond). 1998;94:637-43. [PMID: 9854462]
6. Chin-Dusting JP, Rasaratnam B, Jennings GL, Dudley FJ. Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis. Ann Intern Med. 1997;127:985-8. [PMID: 9412304]
7. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology. 1994;20:1442-9. [PMID: 7982643]
8. Iwanaga S, Morita T, Harada. T, Nakamura S, Niwa M, Takadad K, et al. Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins. Haemostasiss. 1978;7:183-8. [PMID: 658779]
9. Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology. 1988;8:232-6. [PMID: 3281884]
10. Guamer C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology. 1993;18:1139-43. [PMID: 8225220]
11. Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol. 1995;22: 165-72. [PMID: 7790704]
12. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology. 2001;120:726-48. [PMID: 11179247]
13. Arroyo V, Gines P. Arteriolar vasodilation and the pathogenesis of the hyperdynamic circulation and renal sodium and water retention in cirrhosis [Editorial]. Gastroenterology. 1992;102:1077. [PMID: 1537501]
14. Edlund C, Bergan T, Josefsson K, Solberg R, Nord CE. Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics. Scand J Infect Dis. 1987;19:113-21. [PMID: 3563419]
15. Johnson PC, Ericsson CD, Morgan DR, Dupont HL, Cabada FJ. Lack of emergence of resistant fecal flora during successful prophylaxis of travelers diarrhea with norfloxacin. Antimicrob Agents Chemother. 1986;30:671-4. [PMID: 3800342]
16. Gines P, Rimola A, Planas R, Vargas V, Marco F, Almela M, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. 1990;12:716-24. [PMID: 2210673]
17. Chang CS, Chen GH, Lien HC, Yeh HZ. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 1998;28:1187-90. [PMID: 9794900]
18. Deitch EA, Sittig K, Li M, Berg R, Specian RD. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg. 1990;159:79-84. [PMID: 2136788]
19. Triger DR, Boyer TD, Levin J. Portal and systemic bacteraemia and endotoxaemia in liver disease. Gut. 1978;19:935-9. [PMID: 710964]
20. Raij L, Baylis C. Glomerular actions of nitric oxide [Editorial]. Kidney Int. 1995;48:20-32. [PMID: 7564080]
21. Epstein M, Berk DP, Hollenberg NK, Adams DF, Chalmers TC, Abrams HL, et al. Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med. 1970;49:175-85. [PMID: 5452940]